Enzymicals and Syngulon sign a non-exclusive license agreement on the use of Syngulon’s antibiotic free technology to produce enzymes
As Zymergen Buys EnEvolv, Biological Manufacturing Is Ready To Transform How Industry Makes Everything From Airplanes To Air Jordans
SGI-DNA Launches Vmax™ X2, the Most Innovative Product in the Competent Cells Market Since the Discovery of E. coli
Ginkgo Bioworks and Berkeley Lights Bring Unprecedented Speed and Scale to Synthetic Biology with $150MM Collaboration
